• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液尿酸水平的诊断价值(作者译)

[Diagnostic value of the CSF uric acid level (author's transl)].

作者信息

Tsunoda S, Gega A, Utsumi S, Matsuoka Y, Kubota C

出版信息

No Shinkei Geka. 1978 Oct;6(10):971-4.

PMID:724059
Abstract

Uric acid is the end-product of purine metabolism, and purines are the nitrogenous bases derived from the breakdown of nucleic acids. The CSF uric acid level is thought to be the index of the turnover of the nucleic acid and the degree of the cellular destruction in the brain. CSF uric acid levels were investigated in normal controls (30 cases) and in patients with brain tumor (20 cases), microcephalus (8 cases) and craniostenosis (4 cases). The mean values and standard deviations of CSF uric acid levels in normal controls were as follows; Newborn--9 yrs 0.34 +/- 0.09 mg/dl; 10 yrs--19 yrs 0.50 +/- 0.18 mg/dl; 20 yrs--29 yrs 0.46 +/- 0.05 mg/dl; 30 yrs--39 yrs 0.35 +/- 0.10 mg/dl; 40 yrs--49 yrs 0.35 +/- 0.23 mg/dl. Thereafter 0.72 +/- 0.21 mg/dl. The increased CSF uric acid levels after the age of 50 is thought to be due to the cellular destruction in the brain. CSF uric acid levels increased in patients with highly malignant brain tumor such as grade 3 or 4 astrocytoma and sarcomatous meningioma, but were normal in patients with grade 2 astrocytoma and meningiomas of meingothelial or fibroblastic type. CSF uric acid levels decreased in patients with microcephalus, but were almost normal in patients with craniostenosis. There is a significant correlation between CSF uric acid levels and the degree of brain atrophy in infants.

摘要

尿酸是嘌呤代谢的终产物,而嘌呤是核酸分解产生的含氮碱基。脑脊液尿酸水平被认为是核酸周转率及脑内细胞破坏程度的指标。对30例正常对照者、20例脑肿瘤患者、8例小头畸形患者及4例颅骨狭窄患者的脑脊液尿酸水平进行了研究。正常对照者脑脊液尿酸水平的平均值及标准差如下:新生儿至9岁为0.34±0.09mg/dl;10岁至19岁为0.50±0.18mg/dl;20岁至29岁为0.46±0.05mg/dl;30岁至39岁为0.35±0.10mg/dl;40岁至49岁为0.35±0.23mg/dl。此后为0.72±0.21mg/dl。50岁以后脑脊液尿酸水平升高被认为是由于脑内细胞破坏所致。高度恶性脑肿瘤患者,如3级或4级星形细胞瘤及肉瘤样脑膜瘤患者的脑脊液尿酸水平升高,但2级星形细胞瘤及内皮型或纤维母细胞型脑膜瘤患者的脑脊液尿酸水平正常。小头畸形患者的脑脊液尿酸水平降低,但颅骨狭窄患者的脑脊液尿酸水平几乎正常。婴儿脑脊液尿酸水平与脑萎缩程度之间存在显著相关性。

相似文献

1
[Diagnostic value of the CSF uric acid level (author's transl)].脑脊液尿酸水平的诊断价值(作者译)
No Shinkei Geka. 1978 Oct;6(10):971-4.
2
[Clinical value of the sequential study of the uric acid level in the CSF in patients with postoperative meningitis].[术后脑膜炎患者脑脊液尿酸水平序贯研究的临床价值]
No Shinkei Geka. 1985 Jul;13(7):719-24.
3
[Serum immunoglobulin (IgG, IgM, IgA) levels in patients with primary brain tumors (author's transl)].原发性脑肿瘤患者的血清免疫球蛋白(IgG、IgM、IgA)水平(作者译)
No To Shinkei. 1977 Sep;29(9):1005-9.
4
[Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].[脑膜癌病患者脑脊液生化肿瘤标志物的检测]
No Shinkei Geka. 1991 Dec;19(12):1135-41.
5
[Clinical value of the sequential study of the uric acid in CSF in patients with cerebral diseases: Part I. Brain tumor and the effect of irradiation].[脑脊液尿酸水平动态观察对脑部疾病的临床价值:第一部分。脑肿瘤与放疗效果]
No To Shinkei. 1984 Mar;36(3):255-60.
6
[The diagnostic value of immunoglobulin G in the cerebrospinal fluid of brain tumor patients, particularly in malignant tumors].[免疫球蛋白G在脑肿瘤患者脑脊液中的诊断价值,尤其是在恶性肿瘤中的诊断价值]
Gan No Rinsho. 1987 Oct;33(12):1402-6.
7
CSF levels of cyclic nucleotides and adrenergic metabolites in malignant gliomas.恶性胶质瘤中脑脊液环核苷酸和肾上腺素能代谢产物的水平
Surg Neurol. 1980 May;13(5):359-62.
8
[The value of neuron specific enolase (NSE) in patients with brain tumors].[神经元特异性烯醇化酶(NSE)在脑肿瘤患者中的价值]
No To Shinkei. 1987 Feb;39(2):169-73.
9
Cerebrospinal fluid polyamines: biochemical markers of malignant childhood brain tumors.脑脊液多胺:儿童恶性脑肿瘤的生化标志物
Ann Neurol. 1986 Apr;19(4):360-4. doi: 10.1002/ana.410190409.
10
[Biochemical investigation of normal pressure hydrocephalus in the assessment of shunt effectiveness].[正常压力脑积水分流效果评估中的生化研究]
No To Shinkei. 1988 Feb;40(2):163-70.